diagnosis, and an account is given of our experience with this. In 1916 patients who had a successful amniocentesis, results indicative of fetal abnormality were found in 4 *3 % and a balanced translocation was found in an additional 0 9 %o. Results indicative of fetal abnormality were found in 3 *5 % of mothers referred because of a maternal age of 40 or more, 3 .9 % referred because of a high risk of neural tube defect, and 19 *3 % referred because of a high risk of an inborn error of metabolism.
A number of cases with difficult diagnostic problems are described.
The Paediatric Research Unit was set up with the aim of preventing congenital disorders, primarily by pursuing research into causes and by the subsequent application of the research findings through counselling and diagnostic services.
Since the Unit's inception in 1960 about 14 000 kinships have been registered with it, either because one or more members had been referred for diagnosis or advice, or following the discovery of abnormalities in the course of specific population surveys. The latter group was always offered, and often accepted, genetic counselling. From 1971 the chromosome diagnostic work was partly supported by the Department of Health and Social Security on a service basis, and from 1973 the support was extended to amniotic cytology. The South-East Thames Regional Genetics Centre was established in the Unit in 1976 and the Supraregional Laboratory for Tissue Enzymes in 1973. The following is an account of the work of this Unit, and is offered in the hope that the experiences described may be helpful to others who are planning Genetic Centres.
Received for publication 14 August 1978 The major causes for referral by kinship Table 1 gives a broad classification of the causes for referral between 1960 and 1977, and shows how the number of families registered per year has increased since the inception of the Unit. These data are related to workload, but are not identical to it, since many members of one kinship may be seen, or several visits paid by one family. In either case, the families are counted only once, so that the workload is substantially larger than the figures given. On the other hand, not all of those registered have had counselling appointments, since requests for chromosome analysis may be confined to the analysis of a blood sample sent by post. From 1975 post. From to 1977 approximately 50 % of those registered were seen in the Unit. The proportion was greater in earlier years. Before the introduction of prenatal diagnosis or of carrier detection, genetic advice was limited to probability counselling; that is, explaining to families at risk the chances of producing further affected children. The major change which has occurred has been the advent of prenatal diagnosis, but the background work, other than during pregnancy, of cytogenetic diagnosis, biochemistry, and genetic counselling of families has also continued to (Fensom et al., 1974 (Fensom et al., , 1976 (Fensom et al., , 1977 Stirling et al., 1978) , or exploited for the first time (Ramsay et al., 1974; F. G. Giannelli, 1976, personal communication) , so that referrals for these conditions have also increased.
Prenatal diagnosis DEVELOPMENT AND POLICIES IN THE UNIT
From the autumn of 1969, the Unit began to offer a prenatal diagnosis service for chromosome disorders and soon followed this with the offer of prenatal diagnosis of inborn errors of metabolism. From 1972 onwards, a diagnostic service for neural tube defects (NTD) was offered, with the measurement of alphafetoprotein (AFP) in amniotic fluid. Some of the findings have already been published as individual case reports including Seller (1975) , Campbell et al. (1976) , Blunt et al. (1977) , and 546 amniocentesis patients (and their controls) are included in the Medical Research Council (MRC) Working Party on Amniocentesis Report (1978) .
The policy regarding the tests done on a specimen of amniotic fluid changed somewhat over the years. Before 1972 the only 'service' investigations were those done for chromosome analysis. Estimations of AFP levels in all fluids received were carried out immediately after the first published indication of its importance for the diagnosis of NTD (Brock and Sutcliffe, 1972) . Since AFP studies were being done in the Unit (Adinolfi et al., 1975) Of the 2068 mothers who came to amniocentesis, 1814 had one tap only (Table 5) , and the fluid was obtained and successfully analysed in 1694 (93 4%). The remaining 120, in whom no laboratory result was obtained, are dcscribed below. Of the 254 gravidae who had two or more taps, fluid was obtained and successfully analysed in 222 (87-4%).
Thus, the amniocentesis and laboratory failure rates are nearly double those of the mothers requiring only one tap (P<0 01).
In slightly over half of the 152 (120 one tap, 32 two or more) in whom no result was ever obtained, the failure was the result of a blood-stained fluid or a dry tap. In the remainder, there was a laboratory failure to establish diagnostically satisfactory amniotic cell cultures, both types of failure occurring more frequently in the earlier years.
In the 120 mothers who had only one attempt at diagnosis (Table 5 and 6), no further action was taken in 16 (13 %) because fetal death had occurred. There was evidence suggesting that in some of these the fetus had been dead or dying at the time of the first tap. In ten of these, the tap had succeeded but amniotic cell culture failed. However, in two, a brown (but not bloody) supernatant fluid had been observed, in another three, the AFP level had been abnormally high, while in the sixth, the AFP level was so low that fetal death and resorption had been suspected. Of the remaining six mothers without results who had a fetal loss and no second amniocentesis, four had a dry tap, and in one of these the sonicaid fetal heart monitor did not detect any heart sounds and a brown vaginal loss was present. The remaining two aborted after a blood-stained tap. The other 104 outcomes are described in Table 6 . Chromosome anomalies Table 7 shows the distribution of these. Of the 30 pregnancies with unbalanced anomalies shown in this In the three pregnancies which were not terminated, the amniotic fluid had shown karyotype 47,XXY, 47,XXX, and 46,XX/47,XX+fragment, respectively (see below). In each, the parents elected to continue the pregnancy and the children were of normal appearance and behaviour on follow-up.
Of the 17 pregnancies in which the fetus was shown to carry a balanced translocation, 15 continued to term. The sixteenth aborted spontaneously some time after amniocentesis and the last was terminated at another centre because of maternal anxiety. The amniotic fluid findings were confirmed in the latter.
Raised alphafetoprotein Raised AFP levels were found in amniotic fluids from 42 mothers. Of these, 7 subsequently aborted a macerated fetus, and in every case the fluid was a dark brown colour (Seller, 1977) , suggesting that the high value was accounted for by intrauterine death (3 have been mentioned earlier). In 3, the raised AFP level was associated with severe fresh blood contamination of the fluid (Table 8) . However, second samples obtained a week after the first were clear and had a normal AFP value, so the pregnancies were allowed to continue to term and normal infants were delivered. One continued to term because it was a twin pregnancy with one normal and one affected fetus (Campbell et al., 1976) . A total of 31 pregnancies were terminated and in 28 the fetus showed an abnormality (27 NTD including 2 with Meckel's syndrome, one other with multiple anomalies including omphalocele). Of the remaining three, one fetus appeared normal but the placenta was grossly abnormal. In the second, the fetus and placenta were normal; two successive amniotic fluid samples had had raised AFP values, but both were severely blood-stained. At that time we did not recognise the significance of fetal blood contamination. The third was a fluid assayed to confirm the findings of a collaborating centre, and though we confirmed their high AFP value they reported finding a normal fetus on termination.
If we count all these cases, including patients of another centre, the unexplained false-positive rate would be 1 in just over 2000 fluids tested for AFP. On the other hand, as far as our own patients are concerned, the two with raised AFP but no fetal abnormality could be accounted for as described above.
Inborn errors and directly detected X-linked conditions Of 16 affected fetuses detected by direct testing (Table 2) , 8 tested in conjunction with other laboratories were terminated, but are not further considered here. Of the remaining 8, 7 pregnancies were terminated and the diagnosis confirmed (Table 3) , while the eighth (galactosaemia) proceeded to term and the diagnosis was confirmed by enzyme assay on cord blood. Where direct testing was not possible, all 10 pregnancies found to have a fetus of the high risk sex were terminated.
OUTCOME OF PREGNANCY AFTER AMNIOCENTESIS
An important part of the prenatal diagnosis evaluation is to obtain reports on the outcome of all pregnancies. The outcome of the pregnancies that came to amniocentesis, distinguishing those in whom the result of the amniocentesis was and was not known, is given in Some pregnancies with unknown outcome are from mothers resident abroad whom we have been unable to trace, while others resident in this country may still be traced. As one might expect, the highest proportion ofunknown pregnancy outcomes (11* 8 Y.) were in those pregnancies where no result was obtained on amniocentesis. It has been shown (Table 6 ) that in these the risk of fetal or neonatal death was highest, over three times the risk in those in whom results were obtained. This group of unknown results also included the only live birth with a chromosomal abnormality, trisomy 18, missed because amniotic cell culture had failed. There were four (normal) cases in which the sex at birth was different from that reported at amniocentesis; twice it was reported as female where a male was delivered, and twice a male where a female was delivered. In three of these, chromosome analysis of the newborn gave a result in accordance with the phenotypic sex, while the fourth (a boy) has not been karyotyped as he was initially rejected. The former two errors could have been the result of maternal cell contamination, the latter must have been a labelling or laboratory error.
All pregnancies tested because of risk of biochemical disorders have been followed up by enzyme assays on the newborn, and all predictions up to the time of writing (September 1978) have proven accurate.
PROBLEMS OF DIAGNOSIS
Certain puzzling situations presented which are reported here in the hope that the experience may be of use to others. The majority are set out in Table 8 and it can be seen that mosaicism is the chief problem. The two fluids containing both normal male and female cells produced male offspring, so maternal contamination is the most likely explanation.
Mosaicism with an abnormal cell line was found five times. In the first, at culture the proportion of trisomic cells was small (3 of 200), the pregnancy was terminated, but no trisomic cells were identified in the fetus. However, the dermatoglyphic findings were compatible with mosaicism (Polani and Polani, 1969 Tetraploidy is a recognised artefact of amniotic fluid culture (Kohn and Robinson, 1970) , so this finding did not cause undue anxiety. Of more concern was the 45,X result in a mother aged 40. This is a rare anomaly among survivors, though the commonest among conceptions, and is not associated with advancing maternal age. The cells had been difficult to maintain in culture, so that a cultural artefact was suspected, particularly as 45,X cells are known to have a rapid cell cycle and might have outgrown the original cells from which they had been derived. Amniocentesis was repeated and showed cells with a karyotype of 46,XX. The mother was reassured and a normal girl delivered at term. Not included in Table 8 are four apparently balanced translocations (three reciprocal, one centric fusion 13/14) in the amniotic fluid cells. Of these, 3 were found in fluid taken from mothers who had had a previous Down's syndrome infant. In 3, examination of the parental karyotype showed one or other parent to carry the reciprocal translocation and a good prognosis was given. These have been included under 'familial translocation other than Down's'. One fetus was found to have a reciprocal translocation involving chromosomes 2q and 18p that must have arisen de novo assuming paternity was as stated. Though it appeared balanced, it was difficult to be altogether reassuring regarding the prognosis. As an excessive incidence of apparently balanced translocations is found in mentally retarded populations, each de novo translocation must be regarded with suspicion as its effect on the phenotype is unknown. The parents elected to continue the pregnancy and a normal boy was born. When seen at age 2i years, he was physically and developmentally normal and his unusual karyotype was confirmed.
In contrast to chromosomal analysis, in which there is agreement on the recognition of most abnormalities, the cut-off points distinguishing normal from abnormal levels of AFP are largely statistical estimates and their significance can be determined by experience only. In the early years, there were little data on the normal AFP range, and each laboratory tended to use as the cut-off points its own highest estimation in mothers later delivering a normal baby. Moreover, AFP results may be difficult to interpret, particularly when the fluid is contaminated with fetal blood. A Kleihauer test is now always performed on blood-stained fluids to determine the source of the contaminating blood. Detailed ultrasound scanning (by Professor Stuart Campbell) has provided helpful confirmation of an abnormal result in many cases.
Overall, 15 (0 8 %) mothers of the 1916 (Table 2) in whom results were obtained had to be recalled and a possibly ambiguous result discussed with them. This inevitably causes considerable distress. With the use of chromosome banding techniques it is possible that this problem will increase, while greater experience with AFP results in individual laboratories may lead to a diminishing proportion of doubtful findings.
Discussion
Although the major part of the data in this account relates to prenatal diagnosis, we must stress that the results reported here should not be construed to indicate the safety or otherwise of amniocentesis. Information on this can only be derived from ad hoc studies with appropriate controls, such as the one by the National Institute of Child Health and Human Development (1976) or that conducted by the MRC (1978).
CHANGES IN REFERRALS OVER THE YEARS
The wide spread of diagnoses for which patients have been referred (Table 1 ) reflect the technical advances that took place between 1960 and 1976, and their increasing numbers mirror the changes in attitudes of the public and doctors to genetic counselling and its attendant diagnostic procedures. During these 16 years, in keeping with changes in genetic practice, we moved from a chromosome diagnostic and largely risk-giving type of counselling to a situation where direct information could frequently be given on a high risk pregnancy. There has also been a shift towards a more outgoing approach, more effort being directed towards informing the professions and the public of genetic services available by means of circulars, lectures, and the provision of library and information services.
In keeping with national policy these efforts have been concentrated on our own region. It is difficult to ascertain the degree to which we are meeting the needs of the region for genetic services, except in one field, namely prenatal diagnosis on age grounds alone. We know that very few patients are referred elsewhere for this indication (Maryon-Davis, 1978) and we know how many mothers resident in the region we are seeing. We had estimated that in 1971 to 1976 no more than 2 % of mothers giving birth in the 35 to 39 age group, and 12% of the older mothers, had been referred for prenatal diagnosis (Polani et al., 1976) . We now have accurate data for the whole of 1976 and it has been estimated that these proportions were 3 % for the 35 to 39 group and 23 % for the 40 and over group; preliminary figures for 1977 show that about 48% of the latter group had been referred (Alberman et al., 1979) . The low figure for the younger age group reflects our policy of not accepting patients aged less than 38 unless there is some indication other than age. There are little similar data from elsewhere, but Milunsky (1975) estimated that in 1974 only 4-1 % of pregnant women in Massachusetts over 35 years of age had an amniocentesis done for prenatal diagnosis. Mikkelsen (1976) reported that in 1974 this was true in 14 7% of women having children when they were 40 or more in Denmark, though this proportion had apparently doubled in 1975, and Bartsch (1978) found that, in 1976, 25% of mothers of 35 or more in Goteberg, Sweden, had undergone amniocentesis.
AMNIOCENTESIS UPTAKE
We can use the present data on prenatal diagnosis to make some other points. About 1 in 5 pregnant women seeking advice on prenatal diagnosis did not undergo the test. About a quarter of these had aborted spontaneously before the test was carried out. In the remainder, the test was not carried out mostly because it was not indicated for the risk specified, or because the counselling odds suggested a relatively tolerable risk.
SUCCESS RATE
In 7 % of those undergoing amniocentesis for any of the indications, no result was obtained. This figure was lower in those who needed only a single tap.
Galjaard (1976) (also in Niermeijer et al., 1976) quotes lower failure rates based on an inquiry covering 46 centres in 8 countries in Western Europe and a much lower proportion of repeat taps (4 3 % against our 12%). We too find that dry taps or bloodstained fluid are the commonest causes of failure, followed, in order of importance, by failure to establish satisfactory cell cultures. However, some of these failures were related to a suspected sick or dying fetus. We also suspect that culture failure may not be independent of cellular abnormality and therefore does not occur at random. This clearly is important in dictating the course of action when cultures fail in otherwise satisfactory samples of fluid.
RESULTS
The overall fetal abnormality rate agrees with the proportions detected in the 6000 amniocenteses reviewed by Galjaard (1976) , with the annotation in the Lancet (1977) , and with the 10 000 amniocenteses reviewed by Golbus (1978) .
As already reported a number of times (FergusonSmith, 1976; Niermeijer et al., 1976; Polani et al., 1976; Simpson et al., 1976; Sachs et al., 1977; Lancet, 1978; Mikkelsen et al., 1978 We find a similar frequency to that described in published reports of trisomic fetuses in pregnant women who had previously had a trisomic fetus (J. Hamerton, 1976, personal communication; Galjaard, 1976; Golbus, 1978 (2) (3) (4) per 1000) and in 2 failure to recognise trisomy 21. Two of the sexing errors were, like two of ours, misrecognition of a female fetus, an error which clearly must be attributed to a labelling or similar mistake.
In conclusion we find that the proportion of amniocenteses which gave informative results, the proportion of abnormalities according to the indication for the test, and the outcomes of pregnancy are similar to those described in reports from other centres. Where outcome was known, 90% of the pregnancies screened ended in live born babies, 4% were terminated for fetal abnormality, less than 1 % for non-medical reasons, and the remaining 6 % ended as a fetal loss or neonatal death.
As can be expected from a subject that is still new and not fully explored, details are changing and emphasis is shifting. Clearly, for example, the findings of the UK Collaborative Study (1977) on serum AFP will alter the approach to the prenatal diagnosis of NTD. Equally, the changing pattern of parental age at reproduction in most Western societies will shift the age criteria for the selection of pregnancies at high risk for chromosome disorders (Philip et al., 1977; Holmes, 1978) , while the development of better understanding of some inborn errors, and of fetal blood sampling, will enlarge the scope of direct counselling for genetic biochemical anomalies. The major problem in this field that will still remain relates to those abnormalities of structure in which no correlated biochemical or cytological tests exist at present.
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